CX-072
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CX-072, covering 2021-12-01 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas [Phase 1, Phase 2]